 | • レポートコード：MRC2-11QY01114 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は血友病治療薬のグローバル市場について調査・分析したレポートです。種類別（組換え凝固因子濃縮物、血漿由来凝固因子濃縮物、デスモプレシン、抗線溶薬）市場規模、用途別（病院薬局、小売薬局、Eコマース）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別血友病治療薬の競争状況、市場シェア ・世界の血友病治療薬市場：種類別市場規模 2015年-2020年（組換え凝固因子濃縮物、血漿由来凝固因子濃縮物、デスモプレシン、抗線溶薬） ・世界の血友病治療薬市場：種類別市場規模予測 2021年-2026年（組換え凝固因子濃縮物、血漿由来凝固因子濃縮物、デスモプレシン、抗線溶薬） ・世界の血友病治療薬市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、Eコマース） ・世界の血友病治療薬市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、Eコマース） ・北米の血友病治療薬市場分析：米国、カナダ ・ヨーロッパの血友病治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの血友病治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の血友病治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの血友病治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer、Biotest、CSL Behring、Kedrion、Octapharma、Takeda、Novo Nordisk、Bayer、Roche、Biogen ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Hemophilia is a rare disorder in which your blood doesn’t clot normally because it lacks sufficient blood-clotting proteins (clotting factors).
Market Analysis and Insights: Global Hemophilia Treatment Drugs Market
The global Hemophilia Treatment Drugs market size is projected to reach US$ 11160 million by 2026, from US$ 10750 million in 2020, at a CAGR of 3.5%% during 2021-2026.
Global Hemophilia Treatment Drugs Scope and Market Size
Hemophilia Treatment Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hemophilia Treatment Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Hemophilia Treatment Drugs market is segmented into
Recombinant Coagulation Factor Concentrates
Plasma Derived Coagulation Factor Concentrates
Desmopressin
Antifibrinolytic Agents
Segment by Application, the Hemophilia Treatment Drugs market is segmented into
Hospital Pharmacies
Retail Pharmacies
E-commerce
Regional and Country-level Analysis
The Hemophilia Treatment Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Hemophilia Treatment Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Hemophilia Treatment Drugs Market Share Analysis
Hemophilia Treatment Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Hemophilia Treatment Drugs business, the date to enter into the Hemophilia Treatment Drugs market, Hemophilia Treatment Drugs product introduction, recent developments, etc.
The major vendors covered:
Pfizer
Biotest
CSL Behring
Kedrion
Octapharma
Takeda
Novo Nordisk
Bayer
Roche
Biogen
1 Study Coverage
1.1 Hemophilia Treatment Drugs Product Introduction
1.2 Market Segments
1.3 Key Hemophilia Treatment Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Hemophilia Treatment Drugs Market Size Growth Rate by Type
1.4.2 Recombinant Coagulation Factor Concentrates
1.4.3 Plasma Derived Coagulation Factor Concentrates
1.4.4 Desmopressin
1.4.5 Antifibrinolytic Agents
1.5 Market by Application
1.5.1 Global Hemophilia Treatment Drugs Market Size Growth Rate by Application
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 E-commerce
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Hemophilia Treatment Drugs Market Size, Estimates and Forecasts
2.1.1 Global Hemophilia Treatment Drugs Revenue 2015-2026
2.1.2 Global Hemophilia Treatment Drugs Sales 2015-2026
2.2 Global Hemophilia Treatment Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Hemophilia Treatment Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Hemophilia Treatment Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Hemophilia Treatment Drugs Competitor Landscape by Players
3.1 Hemophilia Treatment Drugs Sales by Manufacturers
3.1.1 Hemophilia Treatment Drugs Sales by Manufacturers (2015-2020)
3.1.2 Hemophilia Treatment Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Hemophilia Treatment Drugs Revenue by Manufacturers
3.2.1 Hemophilia Treatment Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Hemophilia Treatment Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Hemophilia Treatment Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Hemophilia Treatment Drugs Revenue in 2019
3.2.5 Global Hemophilia Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Hemophilia Treatment Drugs Price by Manufacturers
3.4 Hemophilia Treatment Drugs Manufacturing Base Distribution, Product Types
3.4.1 Hemophilia Treatment Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Hemophilia Treatment Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Hemophilia Treatment Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Hemophilia Treatment Drugs Market Size by Type (2015-2020)
4.1.1 Global Hemophilia Treatment Drugs Sales by Type (2015-2020)
4.1.2 Global Hemophilia Treatment Drugs Revenue by Type (2015-2020)
4.1.3 Hemophilia Treatment Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Hemophilia Treatment Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Hemophilia Treatment Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Hemophilia Treatment Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Hemophilia Treatment Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Hemophilia Treatment Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Hemophilia Treatment Drugs Market Size by Application (2015-2020)
5.1.1 Global Hemophilia Treatment Drugs Sales by Application (2015-2020)
5.1.2 Global Hemophilia Treatment Drugs Revenue by Application (2015-2020)
5.1.3 Hemophilia Treatment Drugs Price by Application (2015-2020)
5.2 Hemophilia Treatment Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Hemophilia Treatment Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Hemophilia Treatment Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Hemophilia Treatment Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Hemophilia Treatment Drugs by Country
6.1.1 North America Hemophilia Treatment Drugs Sales by Country
6.1.2 North America Hemophilia Treatment Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Hemophilia Treatment Drugs Market Facts & Figures by Type
6.3 North America Hemophilia Treatment Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Hemophilia Treatment Drugs by Country
7.1.1 Europe Hemophilia Treatment Drugs Sales by Country
7.1.2 Europe Hemophilia Treatment Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Hemophilia Treatment Drugs Market Facts & Figures by Type
7.3 Europe Hemophilia Treatment Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Hemophilia Treatment Drugs by Region
8.1.1 Asia Pacific Hemophilia Treatment Drugs Sales by Region
8.1.2 Asia Pacific Hemophilia Treatment Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Hemophilia Treatment Drugs Market Facts & Figures by Type
8.3 Asia Pacific Hemophilia Treatment Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Hemophilia Treatment Drugs by Country
9.1.1 Latin America Hemophilia Treatment Drugs Sales by Country
9.1.2 Latin America Hemophilia Treatment Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Hemophilia Treatment Drugs Market Facts & Figures by Type
9.3 Central & South America Hemophilia Treatment Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Hemophilia Treatment Drugs by Country
10.1.1 Middle East and Africa Hemophilia Treatment Drugs Sales by Country
10.1.2 Middle East and Africa Hemophilia Treatment Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Hemophilia Treatment Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Hemophilia Treatment Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Hemophilia Treatment Drugs Products Offered
11.1.5 Pfizer Related Developments
11.2 Biotest
11.2.1 Biotest Corporation Information
11.2.2 Biotest Description and Business Overview
11.2.3 Biotest Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Biotest Hemophilia Treatment Drugs Products Offered
11.2.5 Biotest Related Developments
11.3 CSL Behring
11.3.1 CSL Behring Corporation Information
11.3.2 CSL Behring Description and Business Overview
11.3.3 CSL Behring Sales, Revenue and Gross Margin (2015-2020)
11.3.4 CSL Behring Hemophilia Treatment Drugs Products Offered
11.3.5 CSL Behring Related Developments
11.4 Kedrion
11.4.1 Kedrion Corporation Information
11.4.2 Kedrion Description and Business Overview
11.4.3 Kedrion Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Kedrion Hemophilia Treatment Drugs Products Offered
11.4.5 Kedrion Related Developments
11.5 Octapharma
11.5.1 Octapharma Corporation Information
11.5.2 Octapharma Description and Business Overview
11.5.3 Octapharma Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Octapharma Hemophilia Treatment Drugs Products Offered
11.5.5 Octapharma Related Developments
11.6 Takeda
11.6.1 Takeda Corporation Information
11.6.2 Takeda Description and Business Overview
11.6.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Takeda Hemophilia Treatment Drugs Products Offered
11.6.5 Takeda Related Developments
11.7 Novo Nordisk
11.7.1 Novo Nordisk Corporation Information
11.7.2 Novo Nordisk Description and Business Overview
11.7.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Novo Nordisk Hemophilia Treatment Drugs Products Offered
11.7.5 Novo Nordisk Related Developments
11.8 Bayer
11.8.1 Bayer Corporation Information
11.8.2 Bayer Description and Business Overview
11.8.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Bayer Hemophilia Treatment Drugs Products Offered
11.8.5 Bayer Related Developments
11.9 Roche
11.9.1 Roche Corporation Information
11.9.2 Roche Description and Business Overview
11.9.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Roche Hemophilia Treatment Drugs Products Offered
11.9.5 Roche Related Developments
11.10 Biogen
11.10.1 Biogen Corporation Information
11.10.2 Biogen Description and Business Overview
11.10.3 Biogen Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Biogen Hemophilia Treatment Drugs Products Offered
11.10.5 Biogen Related Developments
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Hemophilia Treatment Drugs Products Offered
11.1.5 Pfizer Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Hemophilia Treatment Drugs Market Estimates and Projections by Region
12.1.1 Global Hemophilia Treatment Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Hemophilia Treatment Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Hemophilia Treatment Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Hemophilia Treatment Drugs Sales Forecast (2021-2026)
12.2.2 North America: Hemophilia Treatment Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Hemophilia Treatment Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Hemophilia Treatment Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Hemophilia Treatment Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Hemophilia Treatment Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Hemophilia Treatment Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Hemophilia Treatment Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Hemophilia Treatment Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Hemophilia Treatment Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Hemophilia Treatment Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Hemophilia Treatment Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Hemophilia Treatment Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Hemophilia Treatment Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Hemophilia Treatment Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Hemophilia Treatment Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Hemophilia Treatment Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Hemophilia Treatment Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Hemophilia Treatment Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Hemophilia Treatment Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Hemophilia Treatment Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Hemophilia Treatment Drugs Market Segments
Table 2. Ranking of Global Top Hemophilia Treatment Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Hemophilia Treatment Drugs Market Size Growth Rate by Type 2020-2026 (Kg) & (US$ Million)
Table 4. Major Manufacturers of Recombinant Coagulation Factor Concentrates
Table 5. Major Manufacturers of Plasma Derived Coagulation Factor Concentrates
Table 6. Major Manufacturers of Desmopressin
Table 7. Major Manufacturers of Antifibrinolytic Agents
Table 8. Global Hemophilia Treatment Drugs Market Size Growth Rate by Application 2020-2026 (Kg)
Table 9. Global Hemophilia Treatment Drugs Market Size by Region (Kg) & (US$ Million): 2020 VS 2026
Table 10. Global Hemophilia Treatment Drugs Sales by Regions 2015-2020 (Kg)
Table 11. Global Hemophilia Treatment Drugs Sales Market Share by Regions (2015-2020)
Table 12. Global Hemophilia Treatment Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Hemophilia Treatment Drugs Sales by Manufacturers (2015-2020) (Kg)
Table 14. Global Hemophilia Treatment Drugs Sales Share by Manufacturers (2015-2020)
Table 15. Global Hemophilia Treatment Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Hemophilia Treatment Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemophilia Treatment Drugs as of 2019)
Table 17. Hemophilia Treatment Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Hemophilia Treatment Drugs Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Hemophilia Treatment Drugs Price (2015-2020) (USD/Kg)
Table 20. Hemophilia Treatment Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Hemophilia Treatment Drugs Product Type
Table 22. Date of International Manufacturers Enter into Hemophilia Treatment Drugs Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Hemophilia Treatment Drugs Sales by Type (2015-2020) (Kg)
Table 25. Global Hemophilia Treatment Drugs Sales Share by Type (2015-2020)
Table 26. Global Hemophilia Treatment Drugs Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Hemophilia Treatment Drugs Revenue Share by Type (2015-2020)
Table 28. Hemophilia Treatment Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Kg)
Table 29. Global Hemophilia Treatment Drugs Sales by Application (2015-2020) (Kg)
Table 30. Global Hemophilia Treatment Drugs Sales Share by Application (2015-2020)
Table 31. North America Hemophilia Treatment Drugs Sales by Country (2015-2020) (Kg)
Table 32. North America Hemophilia Treatment Drugs Sales Market Share by Country (2015-2020)
Table 33. North America Hemophilia Treatment Drugs Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Hemophilia Treatment Drugs Revenue Market Share by Country (2015-2020)
Table 35. North America Hemophilia Treatment Drugs Sales by Type (2015-2020) (Kg)
Table 36. North America Hemophilia Treatment Drugs Sales Market Share by Type (2015-2020)
Table 37. North America Hemophilia Treatment Drugs Sales by Application (2015-2020) (Kg)
Table 38. North America Hemophilia Treatment Drugs Sales Market Share by Application (2015-2020)
Table 39. Europe Hemophilia Treatment Drugs Sales by Country (2015-2020) (Kg)
Table 40. Europe Hemophilia Treatment Drugs Sales Market Share by Country (2015-2020)
Table 41. Europe Hemophilia Treatment Drugs Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Hemophilia Treatment Drugs Revenue Market Share by Country (2015-2020)
Table 43. Europe Hemophilia Treatment Drugs Sales by Type (2015-2020) (Kg)
Table 44. Europe Hemophilia Treatment Drugs Sales Market Share by Type (2015-2020)
Table 45. Europe Hemophilia Treatment Drugs Sales by Application (2015-2020) (Kg)
Table 46. Europe Hemophilia Treatment Drugs Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Hemophilia Treatment Drugs Sales by Region (2015-2020) (Kg)
Table 48. Asia Pacific Hemophilia Treatment Drugs Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Hemophilia Treatment Drugs Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Hemophilia Treatment Drugs Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Hemophilia Treatment Drugs Sales by Type (2015-2020) (Kg)
Table 52. Asia Pacific Hemophilia Treatment Drugs Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Hemophilia Treatment Drugs Sales by Application (2015-2020) (Kg)
Table 54. Asia Pacific Hemophilia Treatment Drugs Sales Market Share by Application (2015-2020)
Table 55. Latin America Hemophilia Treatment Drugs Sales by Country (2015-2020) (Kg)
Table 56. Latin America Hemophilia Treatment Drugs Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Hemophilia Treatment Drugs Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Hemophilia Treatment Drugs Revenue Market Share by Country (2015-2020)
Table 59. Latin America Hemophilia Treatment Drugs Sales by Type (2015-2020) (Kg)
Table 60. Latin America Hemophilia Treatment Drugs Sales Market Share by Type (2015-2020)
Table 61. Latin America Hemophilia Treatment Drugs Sales by Application (2015-2020) (Kg)
Table 62. Latin America Hemophilia Treatment Drugs Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Hemophilia Treatment Drugs Sales by Country (2015-2020) (Kg)
Table 64. Middle East and Africa Hemophilia Treatment Drugs Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Hemophilia Treatment Drugs Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Hemophilia Treatment Drugs Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Hemophilia Treatment Drugs Sales by Type (2015-2020) (Kg)
Table 68. Middle East and Africa Hemophilia Treatment Drugs Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Hemophilia Treatment Drugs Sales by Application (2015-2020) (Kg)
Table 70. Middle East and Africa Hemophilia Treatment Drugs Sales Market Share by Application (2015-2020)
Table 71. Pfizer Corporation Information
Table 72. Pfizer Description and Major Businesses
Table 73. Pfizer Hemophilia Treatment Drugs Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 74. Pfizer Product
Table 75. Pfizer Recent Development
Table 76. Biotest Corporation Information
Table 77. Biotest Description and Major Businesses
Table 78. Biotest Hemophilia Treatment Drugs Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 79. Biotest Product
Table 80. Biotest Recent Development
Table 81. CSL Behring Corporation Information
Table 82. CSL Behring Description and Major Businesses
Table 83. CSL Behring Hemophilia Treatment Drugs Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 84. CSL Behring Product
Table 85. CSL Behring Recent Development
Table 86. Kedrion Corporation Information
Table 87. Kedrion Description and Major Businesses
Table 88. Kedrion Hemophilia Treatment Drugs Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 89. Kedrion Product
Table 90. Kedrion Recent Development
Table 91. Octapharma Corporation Information
Table 92. Octapharma Description and Major Businesses
Table 93. Octapharma Hemophilia Treatment Drugs Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 94. Octapharma Product
Table 95. Octapharma Recent Development
Table 96. Takeda Corporation Information
Table 97. Takeda Description and Major Businesses
Table 98. Takeda Hemophilia Treatment Drugs Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 99. Takeda Product
Table 100. Takeda Recent Development
Table 101. Novo Nordisk Corporation Information
Table 102. Novo Nordisk Description and Major Businesses
Table 103. Novo Nordisk Hemophilia Treatment Drugs Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 104. Novo Nordisk Product
Table 105. Novo Nordisk Recent Development
Table 106. Bayer Corporation Information
Table 107. Bayer Description and Major Businesses
Table 108. Bayer Hemophilia Treatment Drugs Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 109. Bayer Product
Table 110. Bayer Recent Development
Table 111. Roche Corporation Information
Table 112. Roche Description and Major Businesses
Table 113. Roche Hemophilia Treatment Drugs Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 114. Roche Product
Table 115. Roche Recent Development
Table 116. Biogen Corporation Information
Table 117. Biogen Description and Major Businesses
Table 118. Biogen Hemophilia Treatment Drugs Production (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 119. Biogen Product
Table 120. Biogen Recent Development
Table 121. Global Hemophilia Treatment Drugs Sales Forecast by Regions (2021-2026) (Kg)
Table 122. Global Hemophilia Treatment Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 123. Global Hemophilia Treatment Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 124. Global Hemophilia Treatment Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 125. North America: Hemophilia Treatment Drugs Sales Forecast by Country (2021-2026) (Kg)
Table 126. North America: Hemophilia Treatment Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Europe: Hemophilia Treatment Drugs Sales Forecast by Country (2021-2026) (Kg)
Table 128. Europe: Hemophilia Treatment Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 129. Asia Pacific: Hemophilia Treatment Drugs Sales Forecast by Region (2021-2026) (Kg)
Table 130. Asia Pacific: Hemophilia Treatment Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 131. Latin America: Hemophilia Treatment Drugs Sales Forecast by Country (2021-2026) (Kg)
Table 132. Latin America: Hemophilia Treatment Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Middle East and Africa: Hemophilia Treatment Drugs Sales Forecast by Country (2021-2026) (Kg)
Table 134. Middle East and Africa: Hemophilia Treatment Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 135. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 136. Key Challenges
Table 137. Market Risks
Table 138. Main Points Interviewed from Key Hemophilia Treatment Drugs Players
Table 139. Hemophilia Treatment Drugs Customers List
Table 140. Hemophilia Treatment Drugs Distributors List
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Hemophilia Treatment Drugs Product Picture
Figure 2. Global Hemophilia Treatment Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Recombinant Coagulation Factor Concentrates Product Picture
Figure 4. Plasma Derived Coagulation Factor Concentrates Product Picture
Figure 5. Desmopressin Product Picture
Figure 6. Antifibrinolytic Agents Product Picture
Figure 7. Global Hemophilia Treatment Drugs Sales Market Share by Application in 2020 & 2026
Figure 8. Hospital Pharmacies
Figure 9. Retail Pharmacies
Figure 10. E-commerce
Figure 11. Hemophilia Treatment Drugs Report Years Considered
Figure 12. Global Hemophilia Treatment Drugs Market Size 2015-2026 (US$ Million)
Figure 13. Global Hemophilia Treatment Drugs Sales 2015-2026 (Kg)
Figure 14. Global Hemophilia Treatment Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Hemophilia Treatment Drugs Sales Market Share by Region (2015-2020)
Figure 16. Global Hemophilia Treatment Drugs Sales Market Share by Region in 2019
Figure 17. Global Hemophilia Treatment Drugs Revenue Market Share by Region (2015-2020)
Figure 18. Global Hemophilia Treatment Drugs Revenue Market Share by Region in 2019
Figure 19. Global Hemophilia Treatment Drugs Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Hemophilia Treatment Drugs Revenue in 2019
Figure 21. Hemophilia Treatment Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Hemophilia Treatment Drugs Sales Market Share by Type (2015-2020)
Figure 23. Global Hemophilia Treatment Drugs Sales Market Share by Type in 2019
Figure 24. Global Hemophilia Treatment Drugs Revenue Market Share by Type (2015-2020)
Figure 25. Global Hemophilia Treatment Drugs Revenue Market Share by Type in 2019
Figure 26. Global Hemophilia Treatment Drugs Market Share by Price Range (2015-2020)
Figure 27. Global Hemophilia Treatment Drugs Sales Market Share by Application (2015-2020)
Figure 28. Global Hemophilia Treatment Drugs Sales Market Share by Application in 2019
Figure 29. Global Hemophilia Treatment Drugs Revenue Market Share by Application (2015-2020)
Figure 30. Global Hemophilia Treatment Drugs Revenue Market Share by Application in 2019
Figure 31. North America Hemophilia Treatment Drugs Sales Growth Rate 2015-2020 (Kg)
Figure 32. North America Hemophilia Treatment Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Hemophilia Treatment Drugs Sales Market Share by Country in 2019
Figure 34. North America Hemophilia Treatment Drugs Revenue Market Share by Country in 2019
Figure 35. U.S. Hemophilia Treatment Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 36. U.S. Hemophilia Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Hemophilia Treatment Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 38. Canada Hemophilia Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Hemophilia Treatment Drugs Market Share by Type in 2019
Figure 40. North America Hemophilia Treatment Drugs Market Share by Application in 2019
Figure 41. Europe Hemophilia Treatment Drugs Sales Growth Rate 2015-2020 (Kg)
Figure 42. Europe Hemophilia Treatment Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Hemophilia Treatment Drugs Sales Market Share by Country in 2019
Figure 44. Europe Hemophilia Treatment Drugs Revenue Market Share by Country in 2019
Figure 45. Germany Hemophilia Treatment Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 46. Germany Hemophilia Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Hemophilia Treatment Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 48. France Hemophilia Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Hemophilia Treatment Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 50. U.K. Hemophilia Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Hemophilia Treatment Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 52. Italy Hemophilia Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Hemophilia Treatment Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 54. Russia Hemophilia Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Hemophilia Treatment Drugs Market Share by Type in 2019
Figure 56. Europe Hemophilia Treatment Drugs Market Share by Application in 2019
Figure 57. Asia Pacific Hemophilia Treatment Drugs Sales Growth Rate 2015-2020 (Kg)
Figure 58. Asia Pacific Hemophilia Treatment Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Hemophilia Treatment Drugs Sales Market Share by Region in 2019
Figure 60. Asia Pacific Hemophilia Treatment Drugs Revenue Market Share by Region in 2019
Figure 61. China Hemophilia Treatment Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 62. China Hemophilia Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Hemophilia Treatment Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 64. Japan Hemophilia Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Hemophilia Treatment Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 66. South Korea Hemophilia Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Hemophilia Treatment Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 68. India Hemophilia Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Hemophilia Treatment Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 70. Australia Hemophilia Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Hemophilia Treatment Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 72. Taiwan Hemophilia Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Hemophilia Treatment Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 74. Indonesia Hemophilia Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Hemophilia Treatment Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 76. Thailand Hemophilia Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Hemophilia Treatment Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 78. Malaysia Hemophilia Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Hemophilia Treatment Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 80. Philippines Hemophilia Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Hemophilia Treatment Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 82. Vietnam Hemophilia Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Hemophilia Treatment Drugs Market Share by Type in 2019
Figure 84. Asia Pacific Hemophilia Treatment Drugs Market Share by Application in 2019
Figure 85. Latin America Hemophilia Treatment Drugs Sales Growth Rate 2015-2020 (Kg)
Figure 86. Latin America Hemophilia Treatment Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Hemophilia Treatment Drugs Sales Market Share by Country in 2019
Figure 88. Latin America Hemophilia Treatment Drugs Revenue Market Share by Country in 2019
Figure 89. Mexico Hemophilia Treatment Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 90. Mexico Hemophilia Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Hemophilia Treatment Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 92. Brazil Hemophilia Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Hemophilia Treatment Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 94. Argentina Hemophilia Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Hemophilia Treatment Drugs Market Share by Type in 2019
Figure 96. Latin America Hemophilia Treatment Drugs Market Share by Application in 2019
Figure 97. Middle East and Africa Hemophilia Treatment Drugs Sales Growth Rate 2015-2020 (Kg)
Figure 98. Middle East and Africa Hemophilia Treatment Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Hemophilia Treatment Drugs Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Hemophilia Treatment Drugs Revenue Market Share by Country in 2019
Figure 101. Turkey Hemophilia Treatment Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 102. Turkey Hemophilia Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Hemophilia Treatment Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 104. Saudi Arabia Hemophilia Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Hemophilia Treatment Drugs Sales Growth Rate (2015-2020) (Kg)
Figure 106. U.A.E Hemophilia Treatment Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Hemophilia Treatment Drugs Market Share by Type in 2019
Figure 108. Middle East and Africa Hemophilia Treatment Drugs Market Share by Application in 2019
Figure 109. North America Hemophilia Treatment Drugs Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 110. North America Hemophilia Treatment Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Hemophilia Treatment Drugs Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 112. Europe Hemophilia Treatment Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Hemophilia Treatment Drugs Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 114. Asia Pacific Hemophilia Treatment Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Hemophilia Treatment Drugs Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 116. Latin America Hemophilia Treatment Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Hemophilia Treatment Drugs Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 118. Middle East and Africa Hemophilia Treatment Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
血友病A・B組換え因子補充療法の世界市場（～2026年） Haemophilia is a group of inherited genetic disorders which causes abnormal or exaggerated bleeding. It impairs the normal mechanism of blood clotting after an injury. Internal bleeding inside the joint or inside brain is commonly seen in the patients with severe to moderate haemophilia. Its symptom…- 血友病薬の世界市場（～2026年） The hemophilia treatment drugs market is experiencing entry of a large number of new drugs in the market. Few of them have already arrived and other long lasting clotting factors and more promising drugs are on their way to get launched in this market. For instance, follow up data from phase I/II st…
- 第IX因子欠乏症治療の世界市場（～2026年） Factor IX (or Christmas factor) is one of the serine proteases of the coagulation system; it belongs to peptidase family S1. Deficiency of this protein causes hemophilia B. In this market study, analysts have estimated the prophylaxis segment to dominate the factor IX deficiency treatment market dur…
- 第VIII因子欠乏症治療の世界市場（～2026年） Factor VIII is an essential blood-clotting protein, which is also known as an antihemophilic factor. In individuals, factor VIII is encoded by F8 gene. Defects in F8 gene lead to hemophilia A, a recessive X-linked coagulation disorder. Factor VIII is generated in liver sinusoidal cells and endotheli…
- 凝固因子濃縮物の世界市場（～2026年） Market Analysis and Insights: Global Coagulation Factor Concentrates Market The global Coagulation Factor Concentrates market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Coagulation Factor Concentrates Scope and Market Si…